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Introduction
Foods contain various substances that can control the physio-
logical functions of the body, and modulating immune
responses is one of the most important functions of foods.
Immune functions are indispensable for defending the body
against attack by pathogens or cancer cells, and thus play a
pivotal role in the maintenance of health. However, the
immune functions are disturbed by malnutrition, aging, physi-
cal and mental stress or undesirable lifestyle. Therefore, the
ingestion of foods with immune-modulating activities is
considered an efficient way to prevent immune functions from
declining and reduce the risk of infection or cancer.
In order to establish a diet capable of preserving immune
functions, it is necessary to search and systematize reliable
results on the immune-modulating effects of food-derived
substances. To this end, we have selected reports that evaluated
the immune-modulating abilities of foods in an intervention
study or a randomized controlled trial. Thereafter, we classified
these studies according to the physical state of their subjects into
three categories: (i) studies examining immune parameters of
healthy individuals whose immune functions are poorer than
expected; (ii) studies analyzing immune parameters of patients
with hypersensitivity; and (iii) studies checking immune param-
eters of immunocompromized subjects, including patients who
had undergone surgical resection of cancer and newborns. 
We found that the measurement of at least one parameter repre-
senting either innate or acquired immunity was useful for evalu-
ating the immune-modulating abilities of foods. This review
summarizes the immune-modulating characteristics of foods that
have been verified in human as well as animal studies. In addi-
tion, we briefly describe the pathways by which food-derived
substances are absorbed into the body and the mechanisms
through which food-derived substances exert their immune-
modulating effects.
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Evidence is rapidly accumulating as to the beneficial effects of foods. However, it is not always clear
whether the information is based on data evaluated impartially in a scientific fashion. Human research
into whether foods modulate immune functions in either intervention studies or randomized controlled
trials can be classified into three categories according to the physical state of subjects enrolled for
investigation: (i) studies examining the effect of foods in healthy individuals; (ii) studies analyzing the
effect of foods on patients with hypersensitivity; and (iii) studies checking the effect of foods on
immunocompromized subjects, including patients who had undergone surgical resection of cancer and
newborns. The systematization of reported studies has made it reasonable to conclude that foods are able
to modulate immune functions manifesting as either innate immunity (phagocytic activity, NK cell
activity) or acquired immunity (T cell response, antibody production). Moreover, improvement of
immune functions by foods can normalize the physical state of allergic patients or cancer patients,
and may reduce the risk of diseases in healthy individuals. Therefore, it is valuable to assess the
immune-modulating abilities of foods by measuring at least one parameter of either innate or acquired
immunity.
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Molecules found in foods can be absorbed by multiple routes.
Carbohydrates, proteins and lipids are broken down into
monosaccharides, amino acids and fatty acids, respectively, by
diverse hydrolases secreted in the gut lumen or associated with
membranes of intestinal epithelial cells (IECs). These food
components are actively transported via specific carrier
molecules on the surface membrane of IECs and used as
nutrients (Fig. 1). Vitamins and minerals in foods are also
absorbed through IECs by passive diffusion or active transport
using specific carrier molecules (Fig. 1). The main role of
vitamins and minerals is to regulate the various physiological
functions of cells.
Indigestible macromolecules such as rigid proteins are
incorporated into Peyer’s patches (PPs) developing throughout
the intestine (1). PPs are organized lymphoid tissues that are
covered by a particular epithelial layer, the follicle-associated
envelope (FAE), and composed of both follicles rich in B cells
and an interfollicular area filled with antigen-presenting cells
and T cells. Horseradish peroxidase (HRP) given orally to
mice was detectable in M cells (microfold cells) within the
FAE (2). Moreover, a study using isolated intestinal loops from
piglets has revealed that the absorptive rate of HRP was higher
in the intestinal segments with PPs than without (3). These
results demonstrate that M cells in FAE are the route for
efficiently incorporating indigestible proteins (Fig. 1). Macro-
molecules incorporated into PPs are taken by antigen-presenting
cells and induce antigen-specific immune responses. On the
other hand, macromolecules with higher molecular size such
as carrageenan (88 110 kDa) are hardly absorbed in the
intestine.
Small molecules can be transported through IECs by endo-
cytosis (Fig. 1). By contrast, food-derived substances are not
usually transported between IECs (paracellular transport),
because IECs closely connected by tight junctions do not
usually allow food-derived substances to pass through.
However, the barrier function of tight junctions is not stiff and
breast milk-derived proteins can be transported without degra-
dation between IECs in newborns (4) (Fig. 1). As the immune
system in newborns is immature, it is reasonable that newborns
incorporate breast milk-derived proteins including lactoferrin
and maternal IgG to protect from infection. In contrast,
dysfunction of the tight junction due to genetic defect is
dangerous. Patients with food allergy have intestines with a
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Figure 1. Mechanisms for transport of food-derived substances. Carbohydrates, proteins and lipids are digested by multiple hydrolases secreted into the gut
lumen and associated with membranes of columnar epithelial cells. Specific carrier molecules transport monosaccharides, amino acids and fatty acids, and vita-
mins and minerals are incorporated by passive diffusion or transported by carrier proteins. In contrast, indigestable macromolecules are incorporated by M cells
present in the follicle-associated envelope of Peyer’s patches or through endocytosis by columnar epithelial cells. The incorporation of foods by diffusion through
intercellular spaces between columnar epithelial cells does not occur except for in newborns or in subjects with a genetic deficiency in a barrier function.eCAM 2004;1(3) 243
reduced barrier function, and therefore an antigenic load in the
gut lumen can be easily incorporated into the body (5).
The intestine and liver are important organs in terms of
supply of nutrition and self-defense, and these organs are
equipped with specialized immune systems. A huge number of
IgA-producing cells and intraepithelial T lymphocytes (IELs)
with unique physiological functions are colonized in the gut
and play a pivotal role in defense against pathogens (6).
Moreover, natural killer (NK) T cells are enriched in liver and
highly effective in the eradication of tumor cells (7). Hazardous
substances (pathogens, toxins and allergens) are recognized as
antigens and activate the immune system, but most gut
antigenic loads (food-derived molecules and indigenous intes-
tinal bacteria) are harmless and the immune response to these
antigens is suppressed in healthy humans (oral tolerance). In
contrast, the immune system of patients with inflammatory
bowel disease responds excessively to the indigenous intestinal
bacteria, causing inflammation in the intestine (8).
It is of great interest that some substances in foods can
open tight junctions between IECs. When the capsianoside
contained in a sweet pepper was added to the apical side of a
monolayer formed by the human IEC line Caco-2, the tight
junctions transiently opened, followed by a drop of electric
resistance between the apical and basal sides (9). While the
tight junction basically acts as a barrier to pathogens or toxic
substances in the intestine, the transient opening of tight
junctions may be so important that antigens can be captured by
dendritic cells in the intestinal lamina propria and immune
responses to these antigens are efficiently evoked (10).
Regulation of Immune Functions by Foods
Immune-modulating abilities of foods have been investigated
in a number of human studies. We tentatively classified these
researches into three categories according to the state of
immune system in subjects enrolled for investigation:
(i) healthy individuals; (ii) patients with hypersensitivity; and
(iii) subjects in immunocompromised state.
Foods Capable of Improving Immune Functions in
Healthy Individuals
Immune functions are not stable and usually fluctuate within
fixed limits. In addition, various endogenous and exogenous
factors can influence immune functions. Corticosteroids sup-
press a broad range of immune functions efficiently and
exhibit anti-inflammatory activity. Malnutrition, aging, stress
and undesirable lifestyle are also factors lowering immune
functions. The elderly exhibit higher susceptibility to infection
than the young, and delayed type hypersensitivity (DTH),
antigen-specific antibody production, the proliferative
response of T cells and the relative proportion of T cells
decline with aging (11–16). Many kinds of physical and mental
stress also disturb immune functions. For instance, a surgical
operation exhausts patients and is accompanied by a decline
in their DTH, and caregivers of dementia patients show a
decrease in NK cell activity, antigen-specific antibody
production and T cell proliferation on account of depression
(17,18). Moreover, NK cell activity deteriorates under not only
mental stress after divorce but also physical stress of heavy
exercise (19–24). It is widely known that systemic malnutri-
tion associated with a deficiency of protein and energy causes
a decline in immune functions and results in susceptibility to
infection (25–28). A deficiency in vitamins and minerals
induces an attenuation of immune functions including phago-
cytic activity, NK cell activity, DTH, antigen-specific antibody
production, and the proliferative response of T cells (29,30). In
addition, NK cell activity and the proliferative response of T
cells decline in patients with chronic fatigue syndrome (31).
The deterioration of immune functions possibly causes loss
of health. A higher risk of infection is closely linked with low
NK cell activity, and increased risk of mortality in the elderly
after pathogenic infection is correlated with a decline in DTH
(32–35). Bodily dysfunctions in chronic fatigue syndrome
patients are negatively correlated with the proliferative
response of T cells (36).
These findings clearly demonstrate that immune functions in
healthy individuals tend to be disturbed by various factors, and
deterioration of health is closely connected with dysregulation
of immune functions. On the other hand, it has been proposed
that food-derived components can improve the immune
functions in healthy individuals. Vitamins, minerals, and fatty
acids enhance DTH (37–40), vitamins and minerals enforce
antigen-specific antibody production (41–45) and vitamins,
minerals and oligosaccharides increase T cells and augment
their proliferative response (30,37,43,46–51). In addition,
vitamins, minerals and lactic acid bacteria promote phagocytic
activity and NK cell activity (30,43,52–61) (Fig. 2). The
ingestion of these foods not only normalizes immune functions
but also reduces the incidence of pathogenic infection
(30,41,43,62–64).
Figure 2. Modulation of immune functions by foods. The immune system is
divided into innate immunity and acquired immunity, and food-derived sub-
stances can modulate either innate or acquired immunity. For example, probi-
otics such as lactic acid bacteria and some vitamins enhance phagocytic
activity and natural killer (NK) cell activity (innate immunity), while vitamins,
minerals, amino acids, fatty acids and oligosaccharides augment T cell
responses and antibody production (acquired immunity). A balance of innate
and acquired immunity is desirable for good health.Summarizing the results reported so far, it is reasonable to
conclude that the effect of foods on immune functions can be
evaluated in healthy subjects by measuring either parameters
concerning innate immunity (phagocytic activity and NK cell
activity) or parameters concerning acquired immunity (DTH,
antigen-specific antibody production, the proliferative
response of T cells and T cell number) (Table 1). Therefore,
despite fears that immune functions may decline due to mal-
nutrition, aging, stress or undesirable lifestyle, one can remain
healthy and reduce the risk of infection or cancer by eating
foods capable of enhancing phagocytic activity, NK cell
activity, DTH, antigen-specific antibody production, the
proliferative response of T cells and/or T cell numbers.
Foods Capable of Improving Clinical Symptoms in
Patients With Hypersensitivity
Immune reactions are usually evoked in response to externally
derived hazardous antigens. However, in patients with hyper-
sensitivity represented by immediate type allergy, immune
reaction to non-toxic antigens and sometimes to the body’s
own molecules is induced. The causes of hypersensitivity are
mainly genetic, but environmental factors, including air
pollution, dietary components and residential conditions,
also play an important role. As clinical condition and immune
parameters change concomitantly in allergic patients, it is
possible to observe the effects of foods by measuring the
immune parameters associated with allergic reactions.
Generation of pro-inflammatory cytokines and chemokines
and expression of cell adhesion molecules are involved in the
progression of allergic diseases including atopic dermatitis,
pollinosis and allergic rhinitis. Levels of pro-inflammatory
cytokines and chemokines increase and the expression of cell
adhesion molecules is enhanced in allergic patients (65–70).
Furthermore, eosinophils as well as mast cells secrete chemical
mediators and worsen the clinical symptoms in the inflam-
matory areas (71,72). In order to establish an objective assess-
ment of the clinical state of allergic patients, a skin test, the
antigen-induced response and the SCORAD score have all
been utilized (73,74).
When the immune parameters representing clinical symptoms
characteristic of atopic dermatitis, pollinosis and allergic rhini-
tis normalize, the patients recover from allergic diseases
(67,75). Therefore, normalization of these immune parameters
by foods is helpful in that allergic patients recover their health
and persons with a predisposition to allergies may avoid
falling ill. Parietaria extract (76,77), herbal extract (78) and
lactic acid bacteria (67,79–89) have been found to suppress
allergic diseases in human subjects as well as animal models.
Based on findings reported to date, we conclude that the
following immune parameters can be used to evaluate the
effects of foods on the clinical symptoms of allergic patients:
(i) parameters to directly assess clinical symptoms in allergic
patients: skin test (75,82), skin-induced response (76), SCO-
RAD score (74,78,90); (ii) parameters that vary in association
with the clinical symptoms of allergic patients: TNF-  level
(65,66,79,91), soluble CD4 level (67), soluble CD23 level or
inducible surface CD23 level (68,78,92), soluble IL-2R level
(67,68,93,94), soluble VCAM level (70,78), amount of
granular protein in eosinophils (ECP, EPX) (67,86,95); (iii)
parameters possibly involved in the clinical symptoms of aller-
gic patients: IgG4 level (75), IL-4/IFN-  production (81,96),
TGF-  level (67,97,98), eosinophil number (81,99) (Table 1).
An allergic reaction is a sequential immune response involving
the processing and presentation of the allergen, activation of
allergen-specific T and B cells, production of IgE against the
allergen, and activation of mast cells and eosinophils triggered
by the allergen. Therefore, food-derived materials could prevent
allergy by counteracting at least one step in the cascade of aller-
gic reactions. It has been reported that a variety of foods contain
substances able to prevent an allergic reaction (100–102).
Foods Capable of Improving Immune Functions in
Subjects in an Immunocompromised State
Cancer patients are usually immunosuppressed and at high risk
of infection due to a reduction of immune functions. Therefore,
foods capable of enhancing the immune responses of cancer
patients with disturbed immune functions are valuable.
Invading pathogenic bacteria or viruses are captured and
killed by phagocytes such as neutrophils and macrophages,
and NK cells recognize and lyse infected cells. Activated NK
cells and T cells produce huge amounts of IFN- ,w h i c h
further augments the anti-bacterial activity of macrophages
(103–106).
Pathogens that have escaped capture by phagocytes or NK
cells are incorporated and processed by professional antigen-
presenting cells, which stimulate T cell clones expressing
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Table 1. Parameters available for evaluating the immune-modulating effects
of foods in humans
Subjects Beneficial changes to parameters induced 
by ingesting foods
Healthy individuals Delayed type hypersensitivity ↑ (37–40),
Antigen-specific antibody antibody 
production ↑ (41–45),
Mitogen- or antigen-induced T cell 
proliferation and T cell number ↑ (46–51),
NK cell activity and phagocytic activity ↑
(52–61)
Patients with hypersensitivity Soluble CD4 level in serum ↓ (67), TNF- 
level in feces ↓ (79),
Inducible surface CD23 level ↓ (78),
soluble IL-2R level in serum ↓ (67,78),
Soluble VCAM level in serum ↓ (78), ECP 
level in feces or serum ↓ (67,86),
IFN-  production ↑ (81), TGF- 
level ↓ (67), eosinophil number ↓ (81)
Subjects in Phagocytic activity ↑ (133), NK cell 
immunocompromised state number ↑ (134,137),
T cell number and IFN-  level in serum ↑ (135),
Delayed type hypersensitivity ↑ (133,135),
NK cell activity ↑ (139), antigen-specific 
antibody production ↑ (140),
T cell number and IgG level in serum ↑ (141)antigen receptors specific for pathogens. Activated 
antigen-specific T cells secrete various arrays of cytokines
necessary for antibody production, and pathogen-specific
antibodies play an important role in the exclusion of pathogens
invading the airway, intestine and urinary tract (107–109). IgA
secreted in the intestinal mucosa can neutralize toxins
produced by pathogens and prevents diarrhea (110), and IgG
circulating in sera is principally for defense against infection
in the upper respiratory tract (107).
The incidence of infection increases and the aggravation of
infectious diseases occurs when innate and acquired immune
functions decline or are insufficient. Patients with undetectable
levels of NK cell activity suffer frequent viral infections and
the transfer of NK cells into suckling mice can render the
recipient mice resistant to infection for murine cytomega-
lovirus (111,112). Patients with Gaucher disease, who were
highly susceptible to serious bacterial infections, had
macrophages with impaired anti-bacterial activity and the rate
of infection among marrow transplant recipients 100–365 days
after transplantation was negatively correlated with the total
number of B cells and monocytes (113,114). On the other
hand, several reports have shown that the improvement of
depressed immune functions by ingesting foods reduced
infection rates and mitigated the severity of infectious disease
(43,115–118). When assessing the anti-infectious capabilities
of foods, phagocytic activity, NK cell activity, T cell number,
production of antigen-specific antibodies and total IgG level
can be regarded as useful parameters.
NK cells exhibit cytotoxic activity against not only infected
cells but also cancer cells (119–121). IFN-  produced by
activated NK cells suppresses the proliferation of cancer cells
and activates cytotoxic T cells and macrophages (122,123).
While NK cells kill cancer cells in an antigen non-specific
manner, cytotoxic T cells recognize specific antigens of cancer
cells for killing. Moreover, macrophages secrete molecules
toxic to cancer cells and induce the apoptosis of cancer cells
(124–126).
The proliferation and metastasis of cancer cells accelerate
when immune functions are disturbed. It has been found that
cancer patients have lower NK cell activity than healthy
controls and persons with lower NK cell activity are subject to
higher rates of cancer incidence, metastasis and aggravation of
cancer (127–131). The macrophages infiltrating solid tumor
have less phagocytic activity (132). On the other hand, when
cancer patients ingest foods capable of improving immune
functions, the prognosis becomes much better (133–137).
Based on the reports of clinical trials with cancer patients,
phagocytic activity, NK cell number, T cell number, DTH and
IFN-  production are all useful immune parameters for assess-
ing the effect of foods on prognosis after surgical operation for
cancer (Table 1). Moreover, it has been reported that NK cell
activity deteriorates in AIDS patients (138), and branched
chain amino acids, probiotics and vitamin A improves 
virus-triggered diseases (139–141).
Newborns exhibit immature immune functions and are vul-
nerable to pathogenic infection. Supplementation of vitamins
eCAM 2004;1(3) 245
in malnourished children and ingestion of probiotics in
newborns enhance immune functions and prevent viral infection
(118,142).
Mechanisms by which Foods Influence
Immune Functions
Food-derived substances incorporated into the body via various
routes modulate immune functions. Taking into consideration
that malnutrition or calorie restriction cause reduced activity
in immune functions, nutritional condition is indispensable
for the development of the immune system (143). Moreover,
food-derived substances exhibit a special role in influencing
immune functions.
The way that food-derived substances modulate immune
functions is either indirect or direct. Comparative analyses of
conventional and germ-free animals revealed that indigenous
intestinal microflora play a pivotal role in the development of
host immune systems. Ingestion of probiotics stabilizes the
intestinal microflora, and normalization of the intestinal
microflora by probiotics could lead to modulation of the host
immune system (144). In addition, probiotics such as lactic
acid bacteria are recognized by specific receptors on the
surface of phagocytic cells. Additionally, vitamins, minerals or
fatty acids affect cellular functions by preserving the cell
membrane or regulating gene expression after being incorpo-
rated into lymphocytes (Fig. 3). One group of foods
represented by lactic acid bacteria stimulates innate immunity
(phagocytic activity, NK cell activity), while other foods,
including vitamins and minerals, activate acquired immunity
(T cell response, antibody production). However, as innate
immunity and acquired immunity are closely linked, both
groups of foods may regulate both immune systems. It has
been reported that various nutrients found in foods exhibit
anti-infectious functions (145). We would like to briefly
Figure 3. Mechanisms by which food-derived substances modulate the
immune functions of cells. Components of probiotics are recognized by cell
surface receptors such as the mannose receptor and Toll-like receptors (TLRs).
It has been clarified that agonists of TLRs transmit signals to DNA by activat-
ing intracellular adaptor molecules such as MyD88. In contrast, vitamins and
minerals prevent the oxidation of cell membranes and affect gene expression.
Furthermore, fatty acids modulate immune functions by stabilizing the cell
membrane and regulate the transcription of genes.describe the pathways by which food-derived substances exert
their immune-modulating abilities.
Probiotics ingested may be partially digested in the gut and
incorporated into M cells present in FAE, and then captured by
dendritic cells or macrophages in the interfollicular area of
PPs. These professional phagocytic cells hold various receptors
on their surface capable of binding common structures of
microbes, the pathogen-associated molecular patterns
(PAMPs). Among the receptors for PAMPs, molecular structure
and functions of TLRs (Toll-like receptors) have been recently
unveiled. Ten TLR families (TLR1–TLR10) have been identi-
fied and ligands recognized by some TLRs have been deter-
mined. TLR2 recognizes peptidoglycans and lipopeptides as
TLR4 does lipoteichoic acids and lipopolysaccharides.
Moreover, the CpG oligonucleotides universally detected in
bacterial DNA are recognized by TLR9. The signaling
response to stimuli recognized by TLRs is mainly mediated by
an intracellular adaptor molecule, MyD88 (myeloid differenti-
ation factor 88). Thereafter, the nuclear transport of NF- B
(nuclear factor- B) is stimulated and de novo synthesis of
cytokines is induced (146). It has been proposed that stimuli
through TLR2 activate both JNK (c-Jun N-terminal kinase)
and ERK (extracellular signal regulated kinase) and induce
production of IL-10, while stimuli through TLR4 activate JNK
and induce production of IL-12 (147).
Immune-modulating effects of amino acids such as gluta-
mine and arginine have been evaluated. Ingestion of glutamine
improved nitrogen retention and lowered incidence of bac-
teremia in patients with trauma, and enteral supplementation
of glutamine-enriched diet enhanced the recovery of immune
functions and reduced the length of hospital stay after surgical
operation in cancer patients (148,149). Glutamine is a nutrient
for immune cells and acts as precursor for glutathione, which
circumvents oxidant stress and improves cell-mediated
immunity. Arginine is a substrate for synthesis of nitric oxide
and improves helper T-cell numbers. Peri-operative feeding of
arginine and n-3 polyunsaturated fatty acids (PUFAs) restored
DTH and decreased infection rates in colorectal cancer
patients (150).
Nucleotides are rich in foods containing nucleic acid/
nucleoprotein and supplementation of nucleotides is important
for growth of infants. Addition of nucleotides increased the
proportion of TCR  -bearing IELs through stimulating IL-7
production by IECs in mice (151), and ingestion of formula
supplemented with nucleotides augmented NK cell activity
and IL-2 production in human infants (152). It remains to be
elucidated whether immune cells may utilize ingested
nucleotides as substrates for synthesis of nucleic acids.
Vitamins and minerals exhibit important immune-modulating
functions by entering cells and regulating gene expression.
Vitamin A affects the differentiation of epithelial cells and
inhibits IFN-  production by T cells at the transcriptional
level, which results in stimulation of antibody-mediated
immune responses (153). Vitamin C prevents the production of
reactive oxygen intermediates and reduces DNA damage in
immune cells. Moreover, vitamin C inhibits the transcription of
NF- B, and down-regulates the production of pro-inflammatory
cytokines (154). Vitamin E is also an anti-oxidant and exerts an
anti-inflammatory effect. Vitamin E stabilizes the membrane
of immune cells and enhances the binding of antigen-presenting
cells and T cells (155).
Minerals prevent the oxidation of lipids in the cell membrane,
which can reduce oxidative stress affecting immune cells. For
instance, selenium is indispensable to the function of reducing
enzymes such as glutathione peroxidase and thioredoxin
reductase, and is needed to stimulate cell-mediated immune
functions (156). Furthermore, zinc may be required for the
translocation and binding of NF- B to DNA (157).
Long-chain PUFAs in foods can modulate immune functions.
Dietary n-3 PUFAs alter the lipid composition of the cell
membrane and regulate the function of immune cells. Antigen-
presenting cells from mice and humans fed n-3 PUFAs
exhibited the capacity to suppress excessive activation of
T cells (158,159). As a result, n-3 PUFAs can act as anti-
inflammatory agents.
Major food-derived substances and their immune-modulating
functions are summarized in Table 2.
CONCLUDING REMARKS
We have reviewed and systematized studies reporting the effects
of food-derived materials on immune functions in intervention
studies or randomized controlled trials in order to clarify
whether the immune-modulating activities of foods have been
evaluated in a scientific manner. This search has revealed the
following points: (i) many foods or food-derived materials
improve or enhance immune functions in a wide range of human
subjects; and (ii) foods with immune-modulating activities
affect either innate or acquired immunity. Phagocytic activity
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Table 2. Major food-derived substances that modulate immune functions
Nutrients/nutricines Immune-modulating functions
Nutrients/calorie Indispensable for normal development of immune 
system
Amino acids
Glutamine Trophic for immune cells, circumvention of oxidant 
stress
Arginine Substrate for synthesis of nitric oxide, enhancement 
of Th cells
Fatty acids
n-3 PUFAs Anti-inflammatory
Vitamins
Vitamin A Regulation of Th1/Th2 balance
Vitamin C Circumvention of oxidant stress
Vitamin E Circumvention of oxidant stress, anti-inflammatory
Minerals
Selenium Stimulation of cell-mediated immune response
Zinc Stimulation of cell-mediated immune response
Nucleotides Stimulation of cell-mediated immune response
Probiotics
Peptidoglycan, Stimulation of IL-12/IL-10 production
lipoteichoic acids
CpG oligonucleotides Anti-inflammatoryeCAM 2004;1(3) 247
and NK cell activity are representative parameters of innate
immunity, and phagocytes and NK cells rapidly kill pathogenic
bacteria, viruses and cancer cells in an antigen-independent
manner. In contrast, DTH, antigen-specific antibody production
and the proliferative response of T cells are major parameters
reflecting acquired immunity, which is responsible for the
antigen-specific exclusion of pathogenic bacteria, viruses and
cancer cells. Many kinds of foods can improve parameters
exhibiting either innate or acquired immunity.
Ingestion of foods does not always change many immune
parameters. Therefore, it is useful to define immune parame-
ters affected by foods. Vitamins, minerals, amino acids, proteins,
carbohydrates or lipids, for example, enhance parameters of
acquired immunity. In contrast, probiotics, including lactic
acid bacteria, mainly augment parameters of innate immunity.
These findings support that food-derived materials act on
different immune cells or distinct molecules of the cells and
improve at least one parameter of either innate or acquired
immunity. In other words, these results mean that one can eval-
uate the immune-modulating abilities of foods by analyzing
parameters of either innate or acquired immunity.
The components in foods that improve immune functions
and the mechanisms by which foods exert immune-modulating
effects are still far from fully understood. To confirm the
scientific basis of the immune-modulating activities of foods,
there is a need to keep on systematizing newly obtained
scientific data on foods.
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